APRT anticorps (AA 1-104)
Aperçu rapide pour APRT anticorps (AA 1-104) (ABIN1885569)
Antigène
Voir toutes APRT AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 1-104
-
Purification
- Purified by antigen-affinity chromatography.
-
Immunogène
- Recombinant protein fragment contain a sequence corresponding to a region within amino acids 1 and 104 of APRT
-
-
-
-
Indications d'application
-
Suggested dilutions:
Western blotting: 1.500-1.3000
Immunohistochemistry: 1.100-1.500
Immunofluorescence: 1.100-1.200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 0.1 M Tris-buffered saline with 10 % Glycerol (pH 7.0).0.01 % Thimerosal was added as a preservative.
-
Agent conservateur
- Thimerosal (Merthiolate)
-
Précaution d'utilisation
- Biohazard Informations: This product contains thimerosal which is hazardous.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
-
-
- APRT (Adenine Phosphoribosyltransferase (APRT))
-
Autre désignation
- APRT
-
Sujet
-
Adenine phosphoribosyltransferase belongs to the purine/pyrimidine phosphoribosyltransferase family.A conserved feature of this gene is the distribution of CpG dinucleotides.This enzyme catalyzes the formation of AMP and inorganic pyrophosphate from adenine and 5-phosphoribosyl-1-pyrophosphate (PRPP).It also produces adenine as a by-product of the polyamine biosynthesis pathway.A homozygous deficiency in this enzyme causes 2,8-dihydroxyadenine urolithiasis.Two transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq]
-
Poids moléculaire
- 15 kDa
-
ID gène
- 353
-
NCBI Accession
- NP_001025189, NM_001030018
-
Pathways
- Ribonucleoside Biosynthetic Process
Antigène
-